The HIV-1 Tat Transactivator Protein: A Therapeutic Target?

IUBMB Life

Volumn 55, Issue 12, 2003, Pages 669-680

  Fulcher, Alex J ^a   Jans, David A ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Importins exportins; Nuclear localisation signals; Nuclear protein import; Transactivation; Translational control

Indexed keywords

KARYOPHERIN; RAN PROTEIN; TRANSACTIVATOR PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CYTOPLASM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NUCLEAR LOCALIZATION SIGNAL; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW; TRANSACTIVATION; TRANSCRIPTION REGULATION; VIROGENESIS;

DRUG DELIVERY SYSTEMS; GENE EXPRESSION REGULATION, VIRAL; GENE PRODUCTS, REV; GENE PRODUCTS, TAT; HIV INFECTIONS; HIV-1; HUMANS; MODELS, BIOLOGICAL; MYRISTATES; RNA, VIRAL; SURAMIN; THIAMINE; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 1642518291     PISSN: 15216543     EISSN: None     Source Type: Journal    
DOI: 10.1080/15216540310001643440     Document Type: Review

References (69)

1. Perelson, A. S., Neumann, A. U., Markowitz, M., Leonard, J. M., and Ho, D. D. (1996) HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271, 1582-1586.
2. Piller, S., Caly, L., and Jans, D.A. (2003) Nuclear import of the pre-integration complex (PIC): the Achilles heel of HIV? Curr. Drug Targets 4, 409-429.
3. Ruben, S., Perkins, A., Purcell, R., Joung, K., Sia, R., Burghoff, R., Haseltine, W. A., and Rosen, C. A. (1989) Structural and functional characterization of human immunodeficiency virus tat protein. J. Virol. 63, 1-8.
4. Fisher, A. G., Feinberg, M. B., Josephs, S. F., Harper, M. E., Marselle, L. M., Reyes, G., Gonda, M. A., Aldovini, A., Debouck, C. M., Gallo, R. C., and Wong-Staal, F. (1986) Nature 320, 367-371.
5. Karn, J. (1999) Tackling Tat. J. Mol. Biol. 293, 235-254.
6. Frankel, A. D., and Young, J. A. T. (1998) HIV-1: fifteen proteins and an RNA. Ann. Rev. Biochem. 67, 1-25.
7. Neuveut, C., and Jeang, K. T. (1996) Recombinant human immunodeficiency virus type 1 genomes with tat unconstrained by overlapping reading frames reveal residues in Tat important for replication in tissue culture. J. Virol. 70, 5572-5581.
8. Bogerd, H. P., Fridell, R. A., Blair, W. S., and Cullen, B. R. (1993) Genetic evidence that the Tat proteins of human immunodeficiency virus types 1 and 2 can multimerize in the eukaryotic cell nucleus. J. Virol. 67, 5030-5034.
9. 1 to TAR governs the species specificity of HIV-1 Tat. EMBO J. 17, 7056-7065.
10. Churcher, M. J., Lamont, C., Hamy, F., Dingwall, C., Green, S. M., Lowe, A. D., Butler, J. G., Gait, M. J., and Karn, J. (1993) High affinity binding of TAR RNA by the human immunodeficiency virus type-1 tat protein requires base-pairs in the RNA stem and amino acid residues flanking the basic region. J. Mol. Biol. 230, 90-110.
11. Bayer, P., Kraft, M., Ejchart, A., Westendorp, M., Frank, R., and Rosch, P. (1995) Structural studies of HIV-1 Tat protein. J. Mol. Biol. 247, 529-535.
12. Siomi, H., Shida, H., Maki, M., and Hatanaka, M. (1990) Effects of a highly basic region of human immunodeficiency virus Tat protein on nucleolar localization. J. Virol. 64, 1803-1807.
13. Berkhout, B., Silverman, R. H., and Jeang, K. T. (1989) Tat transactivates the human immunodeficiency virus through a nascent RNA target. Cell 59, 273-282.
14. Hauber, J., Malim, M. H., and Cullen, B. R. (1989) Mutational analysis of the conserved basic domain of human immunodeficiency virus tat protein. J. Virol. 63, 1181-1187.
15. Efthymiadis, A., Briggs, L. J., and Jans, D. A. (1998) Kinetic characterization of the human retinoblastoma protein bipartite nuclear localization sequence in vivo and in vitro: a comparison with the SV40 large T-antigen NLS. J. Biol. Chem. 273, 1623-1628.
16. Rusnati, M., Tulipano, G., Spillmann, D., Tanghetti, E., Oreste, P., Zoppetti, G., Giacca, M., and Presta, M. (1999) Multiple interactions of HIV-1 Tat protein with size-defined heparin oligosaccharides. J. Biol. Chem. 274, 28198-281205.
17. Kuppuswamy, M., Subramanian, T., Srinivasan, A., and Chinnaduria, G. (1989) Multiple functional domains of Tat, the trans-activator of HIV-1, defined by mutational analysis. Nucleic Acids Res. 17, 3551-3561.
18. Barillari, G., Gendelman, R., Gallo, R. C., and Ensoli, B. (1993) The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence. Proc. Natl. Acad. Sci. USA 90, 7941-7945.
19. Weeks, K. M., and Crothers, D. M. (1991) RNA recognition by Tat-derived peptides: interaction in the major groove? Cell 66, 577-588.
20. Wang, Z., and Rana, T. M. (1996) RNA conformation in the Tat-TAR complex determined by site-specific photo-cross-linking. Biochemistry 35, 6491-6499.
21. Aboul-ela, F., Karn, J., and Varani, G. (1995) The structure of the human immunodeficiency virus type-1 TAR RNA reveals principles of RNA recognition by Tat protein. J. Mol. Biol. 253, 313-332.
22. Wu-Baer, F., Sigman, D., and Gaynor, R. B. (1995) Specific binding of RNA polymerase II to the human immunodeficiency virus transactivating region RNA is regulated by cellular cofactors and Tat. Proc. Natl. Acad. Sci. USA 92, 7153-7157.
23. Wei, P., Garber, M. E., Fang, S. M., Fischer, W. H., and Jones, K. A. (1998) A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 92, 451-462.
24. West, M. J., and Karn, J. (1999) Stimulation of Tat-associated kinase-independent transcriptional clongation from the human immunodeficiency virus type-1 long terminal repeat by a cellular enhancer. EMBO J. 18, 1378-1386.
25. Kiernan, R. E., Vanhulle, C., Schiltz, L., Adam, E., Xiao, H., Maudoux, F., Calomme, C., Burny, A., Nakatani, Y., Jeang, K. T., et al. (1999) HIV-1 tat transcriptional activity is regulated by acetylation. EMBO J. 18, 6106-6118.
26. Benkirane, M., Chun, R. F., Xiao, H., Ogryzko, V. V., Howard, B. H., Nakatani, Y., and Jeang, K. T. (1998) Activation of integrated provirus requires histone acetyltransferase. p300 and P/CAF are coactivators for HIV-1 Tat. J. Biol. Chem. 273, 24898-24905.
27. Chiu, Y. L., Coronel, E., Ho, C. K., Shuman, S., and Rana, T. M. (2001) HIV-1 Tat protein interacts with mammalian capping enzyme and stimulates capping of TAR RNA. J. Biol. Chem. 276, 12959-12566.
28. Harrich, D., Ulich, C., Garcia-Martinez, L. F., and Gaynor, R. B. (1997) Tat is required for efficient HIV-1 reverse transcription. EMBO J. 16, 1224-1235.
29. Weissman, J. D., Brown, J. A., Howcroft, T. K., Hwang, J., Chawla, A., Roche, P. A., Schiltz, L., Nakatani, Y., and Singer, D. S. (1998) HIV-1 tat binds TAFII250 and represses TAFII250-dependent transcription of major histocompatibility class 1 genes. Proc. Natl. Acad. Sci. USA 95, 11601-11606.
30. McMillan, N. A. J., Chun, R. F., Siderovski, D. P., Galabru, J., Toone, W. M., Samuel, C. E., Mak, T. W., Hovanessian, A. G., Jeang, K.-T., et al. (1995) HIV-1 Tat directly interacts with the interferon-induced, double-stranded RNA-dependent kinase, PKR. Virol. 213, 413-424.
31. Nath, A., Conant, K., Chen, P., Scott, C., and Major, E. O. (1999) Transient exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes. A hit and run phenomenon. J. Biol. Chem. 274, 17098-17102.
32. Ensoli, B., Barillari, G., Salahuddin, S. Z., Gallo, R. C., and Wong-Staal, F. (1990) Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 345, 84-86.
33. Ensoli, B., Buonaguro, L., Barillari, G., Fiorelli, V., Gendelman, R., Morgan, R. A., Wingfield, P., and Gallo, R. C. (1993) Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J. Virol. 67, 277-287.
34. Weiss, J. M., Nath, A., Major, E. O., and Berman, J. W. (1999) HIV-1 Tat induces monocyte chemoattractant protein-1-mediated monocyte transmigration across a model of the human blood-brain barrier and up-regulates CCR5 expression on human monocytes. J. Immunol. 163, 2953-2959.
35. Zauli, G., Previati, M., Caramelli, E., Bassini, A., Falcieri, E., Gibellini, D., Bertolaso, L., Bosco, D., Robuffo, I., and Capitani, S. (1995) Exogenous human immunodeficiency virus type-1 Tat protein selectively stimulates a phosphatidylinositol-specific phospholipase C nuclear pathway in the Jurkat T cell line. Eur. J. Immunol. 25, 2695-2700.
36. Schwarze, S., and Dowdy, S. (2000) In vivo protein transduction: intracellular delivery of biologically active proteins, compounds and DNA. Trends Pharm. Sci. 21, 45-48.
37. Ferrari, A., Pellegrini, V., Arcangeli, C., Fittipaldi, A., Giacca, M., and Beltram, F. (2003) Caveolae-mediated internalization of extracellular HIV-1 Tat fusion proteins visualized in real time. Mol. Ther. 8, 284-294.
38. Frankel, A. D., and Pabo, C. O. (1988) Cellular uptake of the tat protein from human immunodeficiency virus. Cell 55, 1189-1193.
39. Jans, D. A., Xiao, C. Y., and Lam, M. H. (2000) Nuclear targeting signal recognition: central control point of nuclear protein transport? Bioessays 22, 532-544.
40. Bayliss, R., Littlewood, T., and Stewart, M. (2000) Structural basis for the interaction between FxFG nucleoporin repeats and importin-beta in nuclear trafficking. Cell 102, 99-108.
41. Michael, W. M., Eder, P. S., and Dreyfuss, G. (1997) The K nuclear shuttling domain: a novel signal for nuclear import and nuclear export in the hnRNP K protein. EMBO J. 16, 3587-3598.
42. Yokoya, F., Imamoto, N., Tachibana, T., and Yoneda, Y. (1999) Beta-catenin can be transported into the nucleus in a Ran-unassisted manner. Mol. Biol. of the Cell 10, 1119-1131.
43. Schmalz, D., Hucho, F., and Buchner, K. (1998) Nuclear import of protein kinase C occurs by a mechanism distinct from the mechanism used by proteins with a classical nuclear localization signal. J. Cell Sci. 111, 1823-1830.
44. Briggs, L. J., Johnstone, R. W., Elliot, R. M., Xiao, C.-Y., Dawson, M., Trapani, J. A., and Jans, D. A. (2000) Novel properties of the CK2-site regulated NLS of the interferon-induced nuclear factor IF1 16. Biochem. J. 353, 69-77.
45. Jans, D. A., Jans, P., Juelich, T., Briggs, L. J., Xiao, C.-Y., and Piller, S. C. (2000) Intranuclear binding by the HIV-1 regulatory protein Vpr is dependent on cytosolic factors. Biochem. Biophys. Res. Commun. 270, 1055-1062.
46. Lixin, R., Efthymiadis, A., Henderson, B., and Jans, D. A. (2001) Novel properties of the nucleolar targeting signal of human angiogenin. Biochem. Biophys. Res. Commun. 284, 185-193.
47. Stauber, R. H., and Pavlakis, G. N. (1998) Intracellular trafficking and interactions of the HIV-1 Tat protein. Virol. 252, 126-136.
48. Truant, R., and Cullen, B. R. (1999) The arginine-rich domains present in human immunodeficiency virus type 1 Tat and Rev function as direct importin beta-dependent nuclear localization signals. Mol. Cell. Biol. 19, 1210-1217.
49. Arzumanov, A., Walsh, A. P., Rajwanshi, V. K., Kumar, R., Wengel, J., and Gait, M. J. (2001) Inhibition of HIV-1 Tat-dependent trans activation by steric block chimeric 2′-O-methyl/LNA oligoribonucleotides. Biochemistry 40, 14645-14654.
50. Jaekel, S., and Görlich, D. (1998) Importin β, RanBP5 and RanBP7 mediate nuclear import of ribosomal proteins in mammalian cells. EMBO J. 17, 4491-4502.
51. Jaekel, S., Albig, W., Kutay, U., Bischoff, F. R., Schwamborn, K., Doenecke, D., and Görlich, D. (1999) The importin β/importin 7 heterodimer is a functional nuclear import receptor for histone H1. EMBO J. 18, 2411-2423.
52. Lam, M. H. C., Briggs, L. J., Hu, W., Martin, T. J., Gillespie, M. T., and Jans, D. A. (1999) Importin β recognizes parathyroid hormone-related protein (PTHrP) with high affinity and mediates its nuclear import in the absence of importin α. J. Biol. Chem. 274, 7391-7398.
53. Forwood, J. K., and Jans, D. A. (2002) Nuclear import of the telomere elongation suppressor TRF1; inhibition by importin α. Biochemistry 41, 9333-9348.
54. Morgavi, P., Bonifuci, N., Pagani, M., Costigliolo, S., Sitia, R., and Rubartelli, A. (1997) The association of HIV-1 Tat with nuclei is regulated by Ca2 + ions and cytosolic factors. J. Biol. Chem. 272, 11256-11260.
55. Shoji, S., Furuishi, K., Ogata, A., Yamataka, K., Tachibana, K., Mukai, R., Uda, A., Harano, K., Matsushita, S., and Misumi, S. (1998) An allosteric drug, o,o'-bismyristoyl thiamine disulfide, suppresses HIV-1 replication through prevention of nuclear translocation of both HIV-1 Tat and NF-kappa B. Biochem. Biophys. Res. Commun. 249, 745-573.
56. Choudhury, I., Wang, L., Stein, S., Rabson, A., and Leibowitz, M. J. (1999) Translational effects of peptide antagonists of Tat protein of human immunodeficiency virus type 1. J. Gen. Virol. 80, 777-782.
57. Vickers, T., Baker, B. F., Cook, P. D., Zounes, M., Buckheit, R. W., Jr., Germany, J., and Ecker, D. J. (1991) Inhibition of HIV-LTR gene expression by oligonucleotides targeted to the TAR element. Nucleic Acid Res. 19, 3359-3368.
58. Kaushik, N., Basu, A., and Pandey, V. N. (2002) Inhibition of HIV-1 replication by anti-transactivation responsive polyamide nucleotide analog. Antiviral Res. 56, 13-27.
59. Lind, K. E., Du, Z., Fujinaga, K., Peterlin, B. M., and James, T. L. (2002) Structure-based computational database screening, in vitro assay, and NMR assessment of compounds that target TAR RNA. Chem. Biol. 9, 185-193.
60. Chandra, A., Demirhan, I., Arya, S. K., and Chandra, P. (1988) D-penicillamine inhibits transactivation of human immunodeficiency virus type-1 (HIV-1) LTR by transactivator protein. FEBS Lett. 236, 282-286.
61. Friedler, A., Friedler, D., Luedtke, N. W., Tor, Y., Loyter, A., and Gilon, C. (2000) Development of a functional backbone cyclic mimetic of the HIV-1 Tat arginine-rich motif. J. Biol. Chem. 275, 23783-23789.
62. Pearson, L., Garcia, J., Wu, F., Modesti, N., Nelson, J., and Gaynor, R. (1990) A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat. Proc. Natl. Acad. Sci. USA 87, 5079-5083.
63. Jiang, M. C., Lin, J. K., and Chen, S. S. (1996) Inhibition of HIV-1 Tat-Mediated Transactivation by Quinacrine and Chloroquine. Biochem. Biophys. Res. Commun. 226, 1-7.
64. Hamy, F., Gelus, N., Zeller, M., Lazdins, J. L., Bailly, C., and Klimkait, T. (2000) Blocking HIV replication by targeting Tat protein. Chem. Biol 7, 669-676.
65. Litovchick, A., Lapidot, A., Eisenstein, M., Kalinkovich, A., and Borkow, G. (2001) Neomycin B-arginine conjugate, a novel HIV-1 Tat antagonist: synthesis and anti-HIV activities. Biochemistry 40, 15612-15623.
66. Litovchick, A., Evdokimov, A. G., and Lapidot, A. (1999) Arginine-aminoglycoside conjugates that bind to HIV transactivation responsive element RNA in vitro. FEBS Lett. 445, 73-79.
67. Popov, S., Dubrovsky, L., Lee, M. A., Pennathur, S., Haffar, O., a, L. A. Y., Tonge, P., Ulrich, P., Rexach, M., Blobel, G., et al. (1996) Critical role of reverse transcriptase in the inhibitory mechanism of CNI-H0294 on HIV-1 nuclear translocation. Proc. Natl. Acad. Sci. USA 93, 11859-11864.
68. Krichevsky, A., Graessmann, A., Nissim, A., Piller, S. C., Zakai, N., and A. Loyter. (2003) Antibody fragments selected by phage display against the nuclear localization signal of the HIV-1 Vpr protein inhibit nuclear import in permeabilized and intact cultured cells. Antibody fragments selected by phage display against the nuclear localisation signal of the HIV-1 Vpr protein inhibit nuclear import in permeabilized and intact cultured cells. Virol. 305, 77-92.
69. Hariton-Gazal, E., Feder, R., Mor, A., Graessmann, A., Brack-Werner, R., Jans, D. A., Gilon, C., and Loyter, A. (2002) Targeting of non karyophilic cell-permeable peptides into the nuclei of intact cells by covalently attached nuclear localization signals. Biochemistry 41, 9208-9214.